Clinical Medical Research Sp. z o.o. — Clinical Trial Site

27 Registered trials

13 Currently recruiting

Organisation

Clinical Medical Research Sp. z o.o.

Location

Katowice, Poland

Identifier

ORG-100043696

Address

Aleja Wojciecha Korfantego 138, 40-156, Poland

Departments

Ambulatoryjna Opieka Specjalistyczna
cardiology department
CLINICAL MEDICAL RESEARCH KORFANTEGO - AMBULATORYJNA OPIEKA SPECJALISTYCZNA
Clinical Medical Research Korfantego – Ambulatoryjna Opieka Specjalistyczna
Clinical Medical Research Sp. z o.o.
Clinical Trial
n/a
NA
Not Applicable
Prywatna Przychodnia Ambulatoryjna

Clinical trials at this site (27)

Search interface

A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating the Safety and Efficacy of PPV-06 Active Immunotherapy… Pending

2024-514388-24-00 Knee osteoarthritis 4
A prospective, controlled, randomized, double blind, 2-arms, parallel-group, multicentre, phase 3 study to investigate effectiveness of Acti… Pending

2024-516284-90-00 rhinosinusitis not requiring antibiotic therapy 5
A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder Recruiting

2025-523202-32-00 Major Depressive Disorder 5 2026-02-26
HF-POLARIS: A research study to look at how well NNC0487-0111 works compared to placebo in people with heart failure and obesity Recruiting

2025-523717-29-00 HFpEF or HFmrEF and obesity 5 2026-04-28
DT-101 in Adults with Major Depressive Disorder Recruiting

2025-522784-15-00 Major Depressive Disorder 4 2026-03-24
ZENITH: Zilebesiran in Patients with Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk … Recruiting

2025-522960-34-00 Established cardiovascular disease 5 2026-02-09
Study to Evaluate Plozasiran in Adults with Hypertriglyceridemia (SHASTA-10 Study) Recruiting

2024-519712-13-00 Hypertriglyceridemia (HTG) 5 2025-12-08
A study to test whether BI 1815368 helps people with an eye condition called diabetic macular edema Recruiting

2024-520384-14-00 Centre-involved diabetic macular edema 4 2025-11-20
Clinical trial of molnupiravir (MK-4482) in adults who have COVID-19 and are not hospitalized, who are at high risk for serious illness from… Recruiting

2023-507227-36-00 SARS-CoV-2 (COVID-19) infection 5 2025-02-21
Cytisine for nicotine-containing electronic cigarette and tobacco cigarette cessation: a randomized placebo-controlled trial Recruiting

2023-504708-27-00 electronic cigarette cessation 5 2024-11-02
A study to test whether vicadrostat (BI 690517) in combination with empagliflozin helps people with heart failure. Recruiting

2023-509706-30-00 Heart failure (HF) 5 2024-10-18
202301CPC Redefine-HF Recruiting

2023-508581-15-00 Heart condition 5 2024-10-08
A study to see how well KarXT is tolerated and how well tolerated it is when taken for long time in participants with psychosis associated w… Recruiting

2023-504151-27-00 Psychosis associated with Alzheimer’s Disease 5 2024-05-09
Allopurinol as a preventive drug in patients with high and very high cardiovascular risk, taking into account the presence of the long-COVID… Recruiting

2024-517610-15-00 hyperuricemia, hypertension, ischemic stroke, intracere 5 2024-03-28
Selatogrel Outcome Study in Suspected Acute Myocardial Infarction Recruiting

2023-505438-85-00 Acute myocardial infarction (AMI) 5 2022-01-12
A Study to Confirm if Fezolinetant Helps Reduce Hot Flashes in Women with Breast Cancer Who Are Having Hormone Therapy Ended

2024-510719-31-00 Moderate to Severe Vasomotor Symptoms (VMS) 5 2025-01-24
Study to Evaluate Plozasiran in Adults with Severe Hypertriglyceridemia (SHASTA-4 Study) Ended

2023-509301-80-00 Severe hypertriglyceridemia (SHTG) 5 2024-11-04
Study to Evaluate Plozasiran in Adults with Hypertriglyceridemia (MUIR-3 Study) Ended

2023-509302-30-00 Hypertriglyceridemia 5 2024-11-04
A study to evaluate the efficacy and safety of AMY109 in women with endometriosis Ended

2023-507289-14-00 Endometriosis 4 2024-10-21
A Phase 3 Randomized, Placebo-Controlled Clinical Study to Evaluate the Efficacy and Safety of MK-0616 in Reducing Major Adverse Cardiovascu… Ended

2022-502781-24-01 ASCVD - Atherosclerotic Cardiovascular Disease 5 2024-06-05
LIBREXIA-AF A Phase 3 Active-controlled Study of Milvexian for Prevention of Cardioembolic Events in Participants with Atrial Fibrillation Ended

2022-501419-15-00 Atrial Fibrillation 5 2023-08-23
A study to learn more about how well elinzanetant works and how safe it is compared to placebo for the treatment of hot flashes caused by an… Ended

2023-508265-33-00 Vasomotor symptoms caused by adjuvant endocrine therapy 5 2022-10-13
A 14-week, multicentre, double-blind, randomised, placebo-controlled phase II study with an 8-week treatment period to assess the efficacy a… Ended

2024-513104-34-00 Major Depressive Disorder 4 2024-11-25
A study to investigate efficacy and safety of OG-6219 twice a day in 3 dose levels compared with Placebo in participants aged 18 to 49 with … Ended

2022-501310-57-00 Endometriosis related pain 4 2024-02-05